Clinical Trial Details
EORTC-55955
Back to Clinical Trials Database
A randomised trial in relapsed ovarian cancer: Early treatment based on CA 125 levels alone vs Delayed treatment based on conventional clinical indicators - MRC OV05 and EORTC/GCCG 55955
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 29-Oct-1998 Date Step1 close: 31-Aug-2005 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 400 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00002895 |
| NCT number | NCT00002895 |
